Citations Database

Submit Your Publication

GenScript services and products have been used extensively by scientists worldwide to improve their research efficiency. Here, we have collected a representation of citations for your reference.

Page: 1/366 Results per page

CD40/CD154 blockade inhibits dendritic cell expression of inflammatory cytokines but not costimulatory molecules.

Authors: Ivana R. Ferrer, Danya Liu, David F. Pinelli, Brent H. Koehn, Linda L. Stempora, and Mandy L. Ford.

Journal: J Immunol. 189(9):4387 - 4395

PubMed ID: 23002440

Products & Services: OVA Peptide (257-264) OVA Peptide (323-339)

Aging-associated B7-DC+ B cells enhance anti-tumor immunity via Th1 and Th17 induction.

Authors: Kei Tomihara, Takako Shin, Vincent J. Hurez, Hideo Yagita, Drew M. Pardoll, Bin Zhang, Tyler J. Curiel, Tahiro Shin.

Journal: Aging Cell. 11(1):128-38

PubMed ID: 22044484

Products & Services: OVA Peptide (323-339) OVA Peptide (257-264)

Natriuretic peptides increase β1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition.

Authors: Qvigstad E, Moltzau LR, Aronsen JM, Nguyen CH, Hougen K, Sjaastad I, Levy FO, Skomedal T, Osnes JB.

Journal: Cardiovasc Res. 85(4):763 - 772

PubMed ID: 19900965

Products & Services: peptide : Atrial Natriuretic Peptide (ANP) Brain Natriuretic Peptide ( BNP ), Human

Reovirus Virotherapy Overrides Tumor Antigen Presentation Evasion and Promotes Protective Antitumor Immunity.

Authors: Shashi A. Gujar, Paola Marcato, Da Pan, and Patrick W.K. Lee.

Journal: Mol Cancer Ther. 9(11):2924 - 2933

PubMed ID: 20978162

Products & Services: OVA Peptide (257-264) LCMV gp33-C41

TLR Agonists That Induce IFN-β Abrogate Resident Macrophage Suppression of T Cells.

Authors: Melisa J. Hamilton, Frann Antignano, Anna von Rossum, Jean-Luc Boucher, Kevin L. Bennewith, and Gerald Krystal.

Journal: J Immunol. 185(8):4545 - 4553

PubMed ID: 20844190

Products & Services: OVA Peptide (257-264) OVA Peptide (323-339)

Hyaluronan binding identifies the most proliferative activated and memory T cells.

Authors: Nina Maeshima, Grace F. T. Poon, Manisha Dosanjh, Jackie Felberg, Sally S. M. Lee, Jennifer L. Cross, Darlene Birkenhead, Pauline Johnson.

Journal: Eur J Immunol. 41(4):1108-19

PubMed ID: 21360702

Products & Services: OVA Peptide (257-264) OVA Peptide (323-339)

Antigen delivery to dendritic cells by poly (propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation.

Authors: Hirosue S, Kourtis IC, van der Vlies AJ, Hubbell JA, Swartz MA.

Journal: Vaccine. 28(50):7897-906

PubMed ID: 20934457

Products & Services: OVA Peptide (257-264) [Ala336]-OVA (323-339)

HMGB1-derived peptide acts as adjuvant inducing immune responses to peptide and protein antigen.

Authors: Saenz R, Souza Cda S, Huang CT, Larsson M, Esener S, Messmer D.

Journal: Vaccine. 28(47):7556-62

PubMed ID: 20800114